ProShares UltraShort Health Care (RXD) Short Interest Ratio & Short Volume

Short interest is the volume of ProShares UltraShort Health Care shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 4,200 shares of RXD short. 2.47% of ProShares UltraShort Health Care's shares are currently sold short. Learn More on ProShares UltraShort Health Care's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.47% of ProShares UltraShort Health Care's floating shares are currently sold short.

2.47% of ProShares UltraShort Health Care's shares are currently sold short. Here is how the short interest of companies compare to ProShares UltraShort Health Care: ProShares UltraShort Nasdaq Biotechnology (4.12%), Global X Health Care Covered Call & Growth ETF (2.64%), Langar Global HealthTech ETF (0.28%), JPMorgan Healthcare Leaders ETF (0.07%), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (3.12%), Virtus LifeSci Biotech Clinical Trials ETF (3.56%), First Trust Nasdaq Pharmaceuticals ETF (1.13%), Harbor Health Care ETF (0.23%), Virtus LifeSci Biotech Products ETF (1.70%), Invesco Nasdaq Biotechnology ETF (0.32%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

Short selling RXD is an investing strategy that aims to generate trading profit from ProShares UltraShort Health Care as its price is falling. RXD shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ProShares UltraShort Health Care occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RXD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXD, twice per month. The most recent reporting period available is June, 30 2025.